Liver Cancer in the Middle East (1st ed. 2021. 2021. xv, 414 S. XV, 414 p. 42 illus. in color. 254 mm)

個数:

Liver Cancer in the Middle East (1st ed. 2021. 2021. xv, 414 S. XV, 414 p. 42 illus. in color. 254 mm)

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版
  • 商品コード 9783030787363

Full Description

This book aims to illuminate the causes, incidence, and treatments of Hepatocellular Carcinoma(HCC) or liver cancer in the politically important and societally diverse region of the Middle East. Taking a flexible and inclusive view, it examines the influences of geography, crops and diet, ethnicity, and local behavior on both diagnosis and outcomes of this disease. Understanding the different causes of liver cancer enables effective strategies for both prevention and early diagnosis while knowledge of the different treatment modalities, their uses and limitations, availability and costs, works to inform rational treatment provision and selection. Divided into four sections, this book considers the causes and clinical syndromes associated with HCC, provides a detailed overview of clinical HCC and treatment modalities, describes country-specific clinical HCC experience and practice, and considers future needs and the potential for HCC collaborations across the region.

Liver Cancer in the Middle East is a useful resource for clinicians seeking insight into the second highest cause of death from cancer worldwide, governments planning social and medical services for their peoples, as well as for international aid agencies prioritizing donations.

Contents

Biological Aspects of HCC.- Changing Etiology and Epidemiology of Human Liver Cancer.- Hepatocarcinogenesis Induced by Environmental.- Exposures in the Middle East.- Obesity and Hepatocellular Carcinoma : Epidemiology and Mechanisms.- Epidemiology of Hepatitis B Virus in the Middle East.- Hepatocellular Carcinoma in the United Arab Emirates.- Overview of Clinical HCC and its Management.- Cost Effective.- Therapies for HCC: Resection and Ablation.- Transarterial Radioembolization in Hepatocellular Carcinoma.- Intra-arterial Chemotherapy and.- Transarterial Chemoembolization in Hepatocellular Carcinoma.- Radiotherapy for Hepatocellular Carcinoma.- Liver Transplantation in Middle East.- Individual Patient Assessment and Therapy Decision-Making in a Live Donor-Based Liver Transplant Institute.- Hepatocellular Cancer in Iran.- Hepatocellular Carcinoma In Kuwait.- Insights on Hepatocellular carcinoma in Saudi Arabia.- Hepatitis C induced Hepatocellular Carcinoma in the Middle East.- Hepatocellular Carcinoma in the Middle East: An Overview.- Current HCC Clinical and Research in Egypt.- Hepatocellular Carcinoma in Turkey - A Review of Disease Epidemiology and Treatment Outcomes.- Targeting c-Met and AXL Crosstalk for the Treatment of Hepatocellular Carcinoma.- Hepatocellular Carcinoma in Morocco.- Hepatocellular Carcinoma in Lebanon and its Association with Thalassemia.- An Overview of Hepatocellular Carcinoma (HCC) in Lebanon: a focus on hepatitis B and thalassemia-related HCC.- Hepatocellular Carcinoma in Pakistan: An Update.- Future Directions.- The Need for Region-Wide HCC Collaborations.

最近チェックした商品